1 | 11033-22-0 | coformycin | coformycin | C11H16N4O5
| | |
2 | | H-HIS-GLU-OH | H-HIS-GLU-OH | C11H16N4O5
| | |
3 | 67187-35-3 | isocoformycin | isocoformycin | C11H16N4O5
| | |
4 | 53634-28-9 | L-His-L-Glu-OH | L-His-L-Glu-OH | C11H16N4O5
| | |
5 | 37460-15-4 | H-γ-Glu-His-OH | H-γ-Glu-His-OH | C11H16N4O5
| 标准品 | |
6 | 2095554-12-2 | 多索茶碱杂质4 | Doxofylline Impurity 4 | C11H16N4O5
| 多索茶碱;杂质对照品 | |
7 | 21435-29-0 | L-Histidine, L-α-glutamyl- | L-Histidine, L-α-glutamyl- | C11H16N4O5
| | |
8 | 52663-90-8 | 2',3'-异亚丙基利巴韦林 | 2',3'-Isopropylidene Ribavirin | C11H16N4O5
| | |
9 | 69313-80-0 | 2',3'-Isopropylidene α-Ribavirin | 2',3'-Isopropylidene α-Ribavirin | C11H16N4O5
| | |
10 | 63813-87-6 | 1,6-dihydro-6-(hydroxymethyl)purine riboside | 1,6-dihydro-6-(hydroxymethyl)purine riboside | C11H16N4O5
| | |
11 | 93893-43-7 | L-histidine, compound with 5-oxo-L-proline (1:1) | L-histidine, compound with 5-oxo-L-proline (1:1) | C11H16N4O5
| | |
12 | 346704-14-1 | 1-[2-[(2,4-二硝基苯基)氨基]乙基氨基]丙-2-醇 | 1-((2-[(2,4-DINITROPHENYL)AMINO]ETHYL)AMINO)PROPAN-2-OL | C11H16N4O5
| | |
13 | 641569-96-2 | 3-[(氨基亚胺甲基)氨基]-4-甲基苯甲酸乙酯硝酸盐 | 3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate | C11H16N4O5
| 胍;中间体;抗癌类;医药中间体;杂质对照品;中间体定制类 | |
14 | 686300-58-3 | 4-氨基-1-[2,3-O-(1-甲基亚乙基)呋喃戊糖基] -1,3,5-三嗪-2(1H)-酮 | 4-aMino-1-[2,3-O-(1-Methylethylidene)pentofuranosyl]-1,3,5-Triazin-2(1H)-one | C11H16N4O5
| | |
15 | 109418-98-6 | Pentanoic acid, 5-[(6-amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)amino]-5-oxo- | Pentanoic acid, 5-[(6-amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)amino]-5-oxo- | C11H16N4O5
| | |